Wednesday, November 2, 2011

Devon Energy's Q3-2011 Earnings Report

Although net earnings fell significantly, Devon Energy reported positive revenues for its third-quarter performance. Third-quarter 2011 net earnings of $1.0 billion, or $2.50 per diluted share represented a 50% decline to the company's bottom line from year-ago net earnings and per diluted shares result of $2.1 billion and $4.7 respectively.Devon’s third-quarter 2010 net earnings represented a one-time $1.5 billion gain in divestiture from sale of assets in Azerbaijan.

Revenues jumped 45% to 3.5 billion and operating margins expanded to 43.9% from 29.7%.
Overall, higher production and rising prices in oil and natural gas liquids reflected positively on sales. Total production of oil, natural gas and natural gas liquids averaged 661,000 oil-equivalent barrels per day (Boe), an 8% increase over year-ago quarter.

Respective to the balance sheet, Devon continued its share buy-back operations by repurchasing $697 million of common stocks. The company has purchased $3.2 billion of stocks till date since its announcement of a $3.5 billion repurchasing initiative.
Operating expenses, particularly lease operating expense (LOE) increased by 6% compared to lease operating expense from the third quarter of 2010.

The company’s decision on its recent divestiture gains is what many investors are anticipating going forward. Shares were up 3.59% on the news as of 1:00 PM today.

-Kelechi Nwokocha

Sunday, October 30, 2011

Endo Pharamceuticals (ENDP) Q3 Results

Endo Pharmaceuticals reported earnings for the third quarter, and beat analyst expectations for both top-line revenues and EPS. ENDP revenues increased 71% to $759 million, driven by organic growth in the branded drugs division and growth in the generics division. Opana ER, Voltaren Gel, and Lidoderm grew 66%, 35%, and 3% respectively, for a total growth in the branded division of 17%. The company continues to effectively integrate acquired companies such as Qualitest, which provided a boon to the generic division and helped grow generic revenues by 17%. The combination of organic growth in the branded division and integration of the generic division has led to impressive sales growth and top-line revenues which exceeded analyst expectations by $9 million.

Operating expenses grew to $271 million from $162 million after acquisitions, but expenses as a percentage of sales remained flat. The company saw $48 million in net income, and EPS of $1.25, representing EPS growth of 45%. Additionally, the firm continues to generate strong operating cash flows, which it will use to pay off debt. The firm continues to perform strongly, as had reaffirmed guidance of $2.8 billion in sales and $4.65 in EPS for the fiscal year. The firm also sees a smooth integration of AMS and Qualitest, and believes the firm will be able to capitalize on more synergies than initially thought.

Friday, October 28, 2011

Ford 3Q11 Earnings

Ford reported third quarter earnings Wednesday that beat the mean street estimate, but fell short of its year over year figure. Revenues beat expectations by a wide margin, coming in at 33.1 billion, an increase of about $4 billion or 14%.Vehicle wholesales were 1.3 million units, up 93,000 or 7% from 2010. Pretax operating profit was $1.9 billion or $0.46 per share – down $111 million from 2010. The Pretax operating profit includes a one-time charge of $350 million for un-realized market-to-market adjustments on commodity hedging for future periods. Third quarter net income was $1.6 billion, or 41 cents per share, a $38 million decrease from third quarter 2010. Ford generated positive automotive operating-related cash flow of $400 million in the third quarter.

In the quarter Ford took a one-time-charge of $350 million to write down valuations of commodity hedging contracts (market-to-market), caused by the swift decline in commodity prices. However CEO Alan Mulally stated that this charge “could be reversed” if commodity prices rise in the future or the company recognizes the benefits from lower input costs. If the one-time charge is taken out, considering it could be reversed at some point in the future, earnings would actually be near $2.3 billion, beating the year-over-year figure.

Also, Ford paid down $1.3 billion in debt over the quarter, positioning the company closer to their target of $10 billion in debt by mid-decade. Ford’s Automotive gross cash exceeded debt by $8.1 billion, an improvement of $10.7 billion from the third quarter a year ago.

Share of Ford traded down ~6% on Wednesday. The negative impact on the stock was a result of management failing to declare a dividend or comment on when dividends will be resumed, despite recently having their credit rating upgraded to one-notch below investment grade. Additionally, management issued end of year guidance that indicated overall sales would be toward the lowering end of the 13 million units the company had previously estimated.

Shares of Ford closed Friday up 0.25% to $12.00

Thursday, October 27, 2011

EW Reports Q3 Earning, SAPIEN valve close to approval

Edwards Lifesciences reported third quarter sales growth of 18.4% ($1.25 billion) from Q3 of last year. Sales were driven by an increased demand for their transcatheter heart valves, along with “sustained strength in clinical care.” Transcatheter heart valve sales for the quarter were reported at $82.6 Million, a 69.1% increase over 2010, making up the largest segment of YTD sales growth. Heart valve therapy sales amounted to $246.1 million, representing 22.7% growth over last year. Diluted EPS came in at .38 a share (compared with 0.43 in the prior year quarter), a penny short of analyst consensus, but in line with management guidance.

EW is currently awaiting FDA approval for SAPIEN, a new, non-invasive transcatheter heart valve implant that would give them a significant lead over their competitors. Management expects SAPIEN sales of $20-$25 Million within the first three months of launch, and $150 to $250 Million in it’s first year. Because of this heavy dependence on SAPIEN sales, EW stock has proven to be highly sensitive to speculation as evidenced by a 5% drop in price on 10/18/11 following rumor that FDA approval would be delayed by 9 months. Following release, EW’s stock rose 6.21% to $72.00 per share. Since then, the stock has climbed an additional 4% and is currently trading at $75.15.

- Chris Garcia, Junior Analyst
- Deven Gould, Healthcare Sector Head

Tuesday, October 25, 2011

Illinois Tool Works 3rd Quarter Earnings

Earlier today, Illinois Tool Works (ITW) reported earnings. They reported  third quarter 2011 diluted income per share from continuing operations of $1.00 compared to the estimated $0.98, a 25 percent increase compared to the 2010 third quarter. Total revenues of $4.581 billion compared to the estimate of $4.56, increased 16.2 percent versus the year-ago period.
Revenues increased 16% primarily due to higher base revenues, acquisition and translation. Operating income was $714 million, which was higher than last year by $95 million. Operating margins of 15.6% were lower by 10 basis points versus last year. The 16.2% revenue increase was primarily due to 3 factors. First, base revenues were up 6.2%, with North American base revenues increasing 7.8% and international base revenues up 4.2%. Next, currency translation increased revenues by 4.7%. Lastly, acquisitions net of divestitures added 5.3% to revenue growth. In addition, margins were lower by 20 basis points due to higher restructuring expenses and the dilutive impact of acquisitions reduced margins by 30 basis points.
The company has now seen net income rise in three straight quarters. In the second quarter, net income rose 18.5% and in the first quarter, the figure rose more than twofold. The company topped expectations last quarter after falling short of forecasts in the second quarter with net income of 96 cents versus a mean estimate of net income of $1.02 per share. “Our financial performance in the third quarter was helped by solid growth in both our total revenues and our organic revenues,” said David B. Speer, chairman and chief executive officer. “Overall, end market demand in the quarter was essentially in line with second quarter levels and our forecast expectations. We also generated strong free operating cash flow in the quarter, allowing us to continue to have a well balanced capital allocation approach around dividends, acquisitions and share repurchase.”
Looking forward, analysts appear increasingly negative about the company’s results for the next quarter. The average estimate for the fourth quarter has moved down from 95 cents a share to 90 cents over the last ninety days. For the fiscal year, the average estimate has moved down from $3.94 a share to $3.74 over the last ninety days. Today as a result of this report, shares of ITW were down $2.58 (-5.35%) to $45.65 per share due to the fact that there is a negative outlook on the fourth quarter and the current situation in Europe.  
-John Astarita 

Monday, October 24, 2011

MCD 3Q Review .. 100 Consecutive Months of Positive Global Comps

McDonalds reported stellar third quarter earnings on Friday before the open. Revenue rose 13.7% to $7.1bn from $6.3bn in the year-ago period. Earnings rose to $1.45 per diluted share, a 12% increase from $1.29 last year. Sales were driven by growth across all areas of the world, and comparable same store sales of 5.0% versus 3.9% consensus.

MCD has increased prices two times this year to offset rising commodity prices (particularly beef), but management commented that prices at supermarkets are rising faster than restaurant prices which provides the company with some cushion. An increasingly diverse menu, with a focus on keeping prices competitive versus peers, has allowed McDonalds to thrive in the current environment – driving in-store traffic and allowing MCD to gain market share.

Jim Skinner, CEO, made some interesting comments regarding the economy and consumer. "We are officially out of the recession, but it hardly feels that way," he said. "Consumers everywhere continue to be cost conscious and hesitant to spend." Estimates are under review but results this quarter support our bullish thesis on shares of MCD. The stock traded up ~3% on the day and has increased ~20% so far this year.

Ian

Sunday, October 23, 2011

UASBIG invests in the Albany Community

On Sunday October 23rd UASBIG participated in the Pine Hills community clean up along with deans leadership council and the Pine Hills Neighborhood Association. About 130 University at Albany students were involved with the event that lasted from 9am to 12pm. UASBIG analysts played an important part in the cleanup and Hudson avenue saw great improvement as a result. Thanks to all who participated!



-Susan